Business Description
Anavex Life Sciences Corp
NAICS : 325412
SIC : 8731
ISIN : US0327973006
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.92 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -3.1 | |||||
3-Year EPS without NRI Growth Rate | -9.9 | |||||
3-Year FCF Growth Rate | 1.7 | |||||
3-Year Book Growth Rate | 57.9 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.85 | |||||
Quick Ratio | 11.85 | |||||
Cash Ratio | 11.51 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.8 | |||||
Shareholder Yield % | -9.96 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -30.63 | |||||
ROA % | -28.1 | |||||
ROIC % | -2251.56 | |||||
ROCE % | -33.31 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.06 | |||||
Price-to-Tangible-Book | 2.07 | |||||
EV-to-EBIT | -2.87 | |||||
EV-to-EBITDA | -2.87 | |||||
EV-to-FCF | -4.65 | |||||
Price-to-Net-Current-Asset-Value | 2.07 | |||||
Price-to-Net-Cash | 2.13 | |||||
Earnings Yield (Greenblatt) % | -34.9 | |||||
FCF Yield % | -10.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return %
Total Annual Return %
Anavex Life Sciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.55 | ||
Beta | 0.27 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 18.632 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 18.632 - 18.632 | ||
Shares Outstanding (Mil) | 82.11 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Anavex Life Sciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Anavex Life Sciences Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Anavex Life Sciences Corp Frequently Asked Questions
What is Anavex Life Sciences Corp(LTS:0HFR)'s stock price today?
When is next earnings date of Anavex Life Sciences Corp(LTS:0HFR)?
Does Anavex Life Sciences Corp(LTS:0HFR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |